A rare B-cell lymphoproliferative disorder: hairy cell leukemia

Razaq, Wajeeha
April 2008
Hem/Onc Today;4/25/2008, Vol. 9 Issue 7, p18
The article features the hairy cell leukemia disease which is a rare B-cell lymphoproliferative disorder. The stated median age at onset is 50 years with a predominance in men. Patients with the disease reportedly have systemic complaints which includes fatigue, weakness and weight loss. The infusion of the drugs pentostatin and cladribine on patients and the durable treatment results are discussed.


Related Articles

  • Disseminated tuberculosis mimicking relapse in hairy cell leukemia. Gogia, A.; Raina, V.; Gupta, R. // Indian Journal of Cancer;Oct-Dec2013, Vol. 50 Issue 4, p375 

    A letter to the editor is presented on the case of a man with hairy cell leukemia.

  • Cell of origin of hairy cell leukemia. Niemitz, Emily // Nature Genetics;Jul2014, Vol. 46 Issue 7, p665 

    The article reports on a study by Omar Abdel-Wahab and colleagues which identified the hematopoietic stem cells (HSCs) as the preleukemic cell of origin for hairy cell leukemia (HCL).

  • Hairy Cell Leukemia in a Young Male: An Unusual Presentation. Kaur, Manveen; Kar, Koushik; Dalal, Varsha; Siraj, Fouzia // Iranian Journal of Pathology;Autumn2016, Vol. 11 Issue 4, p421 

    The article presents a case study of a 28-year-old man who suffered a generalized weakness, fever and cough and was diagnosed with hairy cell leukemia.

  • Hairy cell leukemia with large cells: long disease course with adequate response to therapy. Sun, X; Amin, H M; Freireich, E J; Keating, M J; Kantarjian, H M; Koller, C A; O'Brien, S M; Giles, F; Albitar, M // Leukemia (08876924);Nov2004, Vol. 18 Issue 11, p1912 

    Presents several cases of hairy cell leukemia (HCL), a lymphoproliferative disorder associated with peripheral blood pancytopenia and leukemic infiltration of bone marrow and spleen. Natural history of HCL; Relationship of interferon alpha with possible development of the pulmonary embolism;...

  • pentostatin.  // Royal Society of Medicine: Medicines;2002, p431 

    This article presents information on pentostatin, a cytotoxic drug, an antibiotic in origin, which is used as an treatment for hairy cell leukaemia. Administration is by injection.

  • Emerging oral therapies for multiple sclerosis. Guthrie, Ellen Whipple // Pharmacy Today;Jun2009, Vol. 15 Issue 6, p31 

    The article offers information on an emerging therapies for multiple sclerosis (MS). Oral therapies for MS include cladribine, laquinimod, fingolimod and dimethyl fumarate. It notes that Cladribine is approved as an injectable agent for hairy cell leukemia. Fingolimod will help in circulating...

  • Hairy cell leukaemia presenting as aplastic anaemia. Dixey, J. J.; Gazzard, B. G. // Journal of the Royal Society of Medicine;May1983, Vol. 76 Issue 5, p427 

    The article presents the case of a 47-year-old patient who had hairy cell leukemia (HCL) presenting as aplastic anemia. The patient was admitted with a history of influenza-like illness and fever. Physical examination was normal with no palpable lymphadenopathy. Biopsy results demonstrated...

  • The Utility of BRAF V600E Mutation-Specific Antibody VE1 for the Diagnosis of Hairy Cell Leukemia. Uppal, Guldeep; Ly, Vandi; Zi-Xuan Wang; Bajaj, Renu; Solomides, Charalambos C.; Banks, Peter M.; Medeiros, L. Jeffrey; Peiper, Stephen C.; Gong, Jerald Z. // American Journal of Clinical Pathology;2015, Vol. 143 Issue 1, p120 

    Objectives: BRAF V600E mutation is characteristic of hairy cell leukemia (HCL). A V600E mutation-specific antibody, VE1, has been recently developed. We studied the diagnostic utility of this antibody in HCL and compared it with other B-cell neoplasms. Methods: VE1 activity was assessed using...

  • Extranodal Castleman disease of the extremities: a case report and review of the literature. Eward, William; DeWitt, Suzanne; Brigman, Brian; Kontogeorgakos, Vasilios; Lagoo, Anand // Skeletal Radiology;Nov2014, Vol. 43 Issue 11, p1627 

    Castleman disease is a rare lymphoproliferative disorder of unknown etiology that most commonly presents as a mediastinal nodal mass or, in the extranodal form of the disease, a mass located in the mediastinum or retroperitoneum. It is exceptionally uncommon for Castleman disease to present in...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics